PTGR2 Antibody (N-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q8N8N7 |
---|---|
Clone Names | 100405269 |
Gene ID | 145482 |
---|---|
Other Names | Prostaglandin reductase 2, PRG-2, 15-oxoprostaglandin 13-reductase, Zinc-binding alcohol dehydrogenase domain-containing protein 1, PTGR2, ZADH1 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | PTGR2 (HGNC:20149) |
---|---|
Synonyms | ZADH1 |
Function | Functions as 15-oxo-prostaglandin 13-reductase and acts on 15-keto-PGE1, 15-keto-PGE2, 15-keto-PGE1-alpha and 15-keto-PGE2-alpha with highest activity towards 15-keto-PGE2 (PubMed:19000823). Overexpression represses transcriptional activity of PPARG and inhibits adipocyte differentiation (By similarity). |
Cellular Location | Cytoplasm. |
Tissue Location | Widely expressed.. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene encodes an enzyme involved in the metabolism ofprostaglandins. The encoded protein catalyzes the NADPH-dependentconversion of 15-keto-prostaglandin E2 to15-keto-13,14-dihydro-prostaglandin E2. This protein may also beinvolved in regulating activation of the peroxisomeproliferator-activated receptor. Alternative splicing results inmultiple transcript variants.
References
Wu, Y.H., et al. Structure 16(11):1714-1723(2008)Gao, K., et al. Int. J. Oncol. 32(6):1343-1349(2008)Chou, W.L., et al. J. Biol. Chem. 282(25):18162-18172(2007)Lamesch, P., et al. Genomics 89(3):307-315(2007)Zhang, L., et al. Cytogenet. Genome Res. 103 (1-2), 79-83 (2003) :
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.